Pneumococcal Conjugate Vaccine: Vaccine Reducing Ear Infections in Children

Allen Bell
Every parent knows the sound of a small child crying due to the pain of an ear infection. Children's ear infections have caused countless sleepless nights for both children and adults. A vaccine is significantly preventing this common ailment of childhood.

The development of the vaccine called Pneumoccocal Conjugate Vaccine also called PCV7 has helped diminished the number of infants and toddlers that develop recurrent ear infections. The vaccine was approved for delivery to help safeguard children from potentially deadly strains of meningitis and other pneumococcal diseases such as ear infections.

The vaccine has resulted in a significant drop in repeat ear infections and the need for ear tubes and frequent hospitalizations. The vaccine is given initially at 2,4,and 6 months of age. Most children generally develop at least one ear infection by the time they turn 2 years old.

The vaccine has not only been beneficial to children but adults also. There has been a decline in serious infections such as pneumococcal meningitis in both children and adults.

Ear infections affect 80 percent of children under the age of three. The cost of treatment is around $5 billion each year. Development of PCV7 has greatly decreased the medical cost in this area. Parent though should be aware that their children might still develop infections and keep watch for signs and symptoms.

Signs and symptoms of ear infections in children:

  • Tugging or pulling at their ears
  • Crying more than usual
  • Insomnia
  • Failure to respond to sounds
  • Unusual irritability
  • Fever
  • Fluid draining from the ear
Anytime these symptoms appear you should notify your child's pediatrician immediately. Prolonged incidents of ear infections without treatment can possibly cause hearing loss. Treatment as soon as possible reduces the chance of any complications.

The vaccine, called PCV7, is marketed under the brand name Prevnar in the United States and Canada and as Prevenar elsewhere in the world.

Published by Allen Bell

Allen lives in Colorado Springs, Colorado with his wife and two daughters. He is currently a freelance writer who is working on his first novel.  View profile

  • The vaccine has resulted in a significant drop in repeat ear infections and the need for ear tubes.
  • The vaccine is given initially at 2,4,and 6 months of age.
  • Most children generally develop at least one ear infection by the time they turn 2 years old.
The development of the vaccine called Pneumoccocal Conjugate Vaccine also called PCV7 has helped diminished the number of infants and toddlers that develop recurrent ear infections.

1 Comments

Post a Comment
  • Alisa Elizabeth King Terry6/14/2007

    This is incorrect. Prevnar's own package insert states that their clinical trials only found Prevnar to be 7% effective against ear infections, and that Prevnar should not be relied upon for that purpose. Your information contradicts the manufacturers themselves.

To comment, please sign in to your Yahoo! account, or sign up for a new account.